by Travis Johnson, Stock Gumshoe | July 15, 2020 2:33 pm
High-end newsletter focused on small-cap biotech stocks, using what they call their CASH system to select recommended stocks (Catalysts, large Addressable market, good Science, and a potential Hype story). Wood also edits the “entry level” healthcare investment advisory Healthy Returns.
Source URL: https://www.stockgumshoe.com/reviews/biotech-millionaire/
Copyright ©2020 Stock Gumshoe unless otherwise noted.